ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA Jan-2020-PDF-final.pdf

Drug Safety Update MHRA Jan-2020-PDF-final.pdf
Summary: E-cigarettes use or vaping - reporting suspected adverse reactions, including lung injury: Ondansetron - small increased risk of oral clefts following use in the first 12 weeks of pregnancy. Mecasermin - risk of benign and malignanr neoplasia
File Size: 261KB
File Type: application/pdf
Created: 29 January 2020
Last Modified: 29 January 2020